Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
The Globe and Mail
1m
Stocks Climb on Apple Earnings Results and Benign US Inflation News
Vertex Pharmaceuticals (VRTX) is up more than +4% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. LPL Financial Holdings (LPLA) is ...
51m
Housing market's returns to normalcy, DEI impacts: Wealth
Brad Smith explores the topics most important to your wallet on Wealth. Compass realtor Melanie Atkinson discusses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
New tariffs coming Saturday
Los Angeles wildfire updates
Black boxes recovered
Todd exits NBC News
Cause of death revealed
Cancerous tumor removed
Granted legal personhood
Apologizes for old tweets
Activists call for boycott
Top leaders asked to resign
Hamas confirms death
2 more victims in indictment
'As Tears Go By' singer dies
US inflation ticked higher
Recuses self from Act 10 suit
DOJ sues to block deal
Michigan priest loses license
Inmate's transfer blocked
Searching for joyriders
To raise hourly pay
Partners w/ US national labs
FDA approves painkiller
Nashville bids for franchise
Confirmed interior secretary
Olympic gold medalist dies
Hamas to release American
Shiffrin finishes 10th
Related topics
Vertex Pharmaceuticals
FDA
Food and Drug Administration
Trade
Journavx
Feedback